Patents by Inventor Seyed Hani Najafi-Shoushtari

Seyed Hani Najafi-Shoushtari has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods targeting miR-128 for regulating cholesterol/lipid metabolism
    Patent number: 9789132
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: October 17, 2017
    Assignee: The General Hospital Corporation
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM
    Publication number: 20170042931
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Application
    Filed: October 14, 2016
    Publication date: February 16, 2017
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • Methods targeting miR-128 for regulating cholesterol/lipid metabolism
    Patent number: 9476046
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Grant
    Filed: April 30, 2015
    Date of Patent: October 25, 2016
    Assignee: The General Hospital Corporation
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM
    Publication number: 20150232848
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Application
    Filed: April 30, 2015
    Publication date: August 20, 2015
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • Methods targeting miR-128 for regulating cholesterol/lipid metabolism
    Patent number: 9045749
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Grant
    Filed: January 13, 2012
    Date of Patent: June 2, 2015
    Assignee: The General Hospital Corporation
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari
  • METHODS TARGETING MIR-128 FOR REGULATING CHOLESTEROL/LIPID METABOLISM
    Publication number: 20140051746
    Abstract: Methods for targeting microRNA 128 (miR-128) for regulating cholesterol/lipid metabolism and insulin sensitivity.
    Type: Application
    Filed: January 13, 2012
    Publication date: February 20, 2014
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Anders M. Naar, Seyed Hani Najafi-Shoushtari